MedTrace Logo

Evaluation of the VOT Among Tuberculosis Patients From Lambaréné

NCT05865626 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-05-19

No results posted yet for this study

Summary

This pilot study aimed to assess the feasibility of using an instant messenger to monitor drug intake in tuberculosis patients and to assess cash incentive to improve adherence to drug intake

Conditions

Interventions

OTHER

VOT with and without cash incentive

Here we are interested in the remote monitoring of TB treatment, and the impact that financial motivation can have on compliance with this monitoring. the cross-over here means that participants in each intervention group will at some point receive VOT without motivation and then VOT with motivation, depending on whether they start with one or the other combination

Sponsors & Collaborators

  • Centre de Recherche Médicale de Lambaréné

    lead OTHER

Principal Investigators

  • Bertarnd Lell, prof. · Centre de Recherche Médicale de Lambaréné

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-10
Primary Completion
2020-06-30
Completion
2022-06-30

Countries

  • Gabon

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05865626 on ClinicalTrials.gov